Role of Mannose-Binding Lectin Deficiency in HIV-1 and Schistosoma Infections in a Rural Adult Population in Zimbabwe

Background Polymorphism in the MBL2 gene lead to MBL deficiency, which has been shown to increase susceptibility to various bacterial, viral and parasitic infections. We assessed role of MBL deficiency in HIV-1 and schistosoma infections in Zimbabwean adults enrolled in the Mupfure Schistosomiasis and HIV Cohort (MUSH Cohort). Methods HIV-1, S. haematobium and S. mansoni infections were determined at baseline. Plasma MBL concentration was measured by ELISA and MBL2 genotypes determined by PCR. We calculated and compared the proportions of plasma MBL deficiency, MBL2 structural variant alleles B (codon 54A>G), C (codon 57A>G), and D (codon 52T>C) as well as MBL2 promoter variants -550(H/L), -221(X/Y) and +4(P/Q) between HIV-1 and schistosoma co-infection and control groups using Chi Square test. Results We assessed 379 adults, 80% females, median age (IQR) 30 (17–41) years. HIV-1, S. haematobium and S. mansoni prevalence were 26%, 43% and 18% respectively in the MUSH baseline survey. Median (IQR) plasma MBL concentration was 800μg/L (192-1936μg/L). Prevalence of plasma MBL deficiency was 18% with high frequency of the C (codon 57G>A) mutant allele (20%). There was no significant difference in median plasma MBL levels between HIV negative (912μg/L) and HIV positive (688μg/L), p = 0.066. However plasma MBL levels at the assay detection limit of 20μg/L were more frequent among the HIV-1 infected (p = 0.007). S. haematobium and S. mansoni infected participants had significantly higher MBL levels than uninfected. All MBL2 variants were not associated with HIV-1 infection but promoter variants LY and LL were significantly associated with S. haematobium infection. Conclusion Our data indicate high prevalence of MBL deficiency, no evidence of association between MBL deficiency and HIV-1 infection. However, lower plasma MBL levels were protective against both S. haematobium and S. mansoni infections and MBL2 promoter and variants LY and LL increased susceptibility to S. haematobium infection.

[1]  Jai K. Das,et al.  Global burden of childhood diarrhea and interventions , 2014, Current opinion in infectious diseases.

[2]  Jai K Das,et al.  Global burden, distribution, and interventions for infectious diseases of poverty , 2014, Infectious Diseases of Poverty.

[3]  B. Stray-Pedersen,et al.  How does mother-to-child transmission of HIV differ among African populations? Lessons from MBL2 genetic variation in Zimbabweans. , 2014, Omics : a journal of integrative biology.

[4]  Hui Li,et al.  Replication study in Chinese Han population and meta-analysis supports association between the MBL2 gene polymorphism and HIV-1 infection. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[5]  L. Singh,et al.  MBL2 Variations and Malaria Susceptibility in Indian Populations , 2013, Infection and Immunity.

[6]  P. Kremsner,et al.  Mannose-Binding Lectin and Susceptibility to Schistosomiasis , 2013, The Journal of infectious diseases.

[7]  M. Battegay,et al.  Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients , 2012, PloS one.

[8]  L. Vatten,et al.  Mannose-Binding Lectin Deficiency Is Associated with Myocardial Infarction: The HUNT2 Study in Norway , 2012, PloS one.

[9]  K. Brouwer,et al.  Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study , 2011, BMC international health and human rights.

[10]  E. Sprinz,et al.  The role of mannose-binding lectin gene polymorphisms in susceptibility to HIV-1 infection in Southern Brazilian patients , 2011, AIDS.

[11]  T. Apollo,et al.  Schistosomiasis infection among school children in the Zhaugwe resettlement area, Zimbabwe April 2005. , 2010, The Central African journal of medicine.

[12]  L. Liu,et al.  A clinical case–control study on the association between mannose‐binding lectin and susceptibility to HIV‐1 infection among northern Han Chinese population , 2010, International journal of immunogenetics.

[13]  Sa Azin,et al.  An overview on the 2008 UNAIDS Report on the 2008 UNAIDS Report on the Global AIDS Epidemic. , 2010 .

[14]  B. Sigaúque,et al.  Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency , 2010, European Respiratory Journal.

[15]  Xinliang Shen,et al.  Association between mannose-binding lectin and HIV infection and progression in a Chinese population. , 2009, Molecular immunology.

[16]  B. Sigaúque,et al.  Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children. , 2009, Tissue antigens.

[17]  R. Hayes,et al.  Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  A. Vallinoto,et al.  Characterization of polymorphisms in the mannose-binding lectin gene promoter among human immunodeficiency virus 1 infected subjects. , 2008, Memorias do Instituto Oswaldo Cruz.

[19]  K. Brouwer,et al.  The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  A. Mangano,et al.  Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression. , 2008, The Journal of infectious diseases.

[21]  M. Boermeester,et al.  Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  B. Agan,et al.  Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. , 2008, The Journal of infectious diseases.

[23]  N. Klein,et al.  Mannose-binding lectin in HIV infection. , 2008, Future virology.

[24]  I. D. de Messias-Reason,et al.  The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. , 2007, The Journal of infectious diseases.

[25]  N. French,et al.  AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid , 2007, Respiratory research.

[26]  G. Werneck,et al.  Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications. , 2007, The Journal of infectious diseases.

[27]  Luc Kestens,et al.  Human schistosomiasis , 2006, The Lancet.

[28]  M. Clerici,et al.  Synergy between mannose-binding lectin gene polymorphisms and supplementation with vitamin A influences susceptibility to HIV infection in infants born to HIV-positive mothers. , 2006, The American journal of clinical nutrition.

[29]  N. Klein,et al.  Mannose‐binding lectin in innate immunity: past, present and future , 2006, Tissue antigens.

[30]  C. Rodríguez-Gallego,et al.  Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population. , 2006, Molecular immunology.

[31]  H. Ullum,et al.  Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. , 2006, Clinical Infectious Diseases.

[32]  H. Ullum,et al.  Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. , 2005, The Journal of infectious diseases.

[33]  M. Yazdanbakhsh,et al.  Schistosome glycans and innate immunity , 2005, Parasite immunology.

[34]  H. Ullum,et al.  Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. , 2005, The Journal of infectious diseases.

[35]  H. Gewurz,et al.  Mannose binding lectin (MBL) and HIV. , 2005, Molecular immunology.

[36]  Lin He,et al.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.

[37]  S. Madhi,et al.  Mannan‐Binding Lectin and RSV Lower Respiratory Tract Infection Leading to Hospitalization in Children: A Case–Control Study from Soweto, South Africa , 2004, Scandinavian journal of immunology.

[38]  M. Tanner,et al.  Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. , 2003, The American journal of tropical medicine and hygiene.

[39]  P. Garred,et al.  Mannose-binding lectin deficiency--revisited. , 2003, Molecular immunology.

[40]  Robert B Sim,et al.  Mannose-Binding Lectin Is a Disease Modifier in Clinical Malaria and May Function as Opsonin for Plasmodium falciparum- Infected Erythrocytes , 2003, Infection and Immunity.

[41]  R. Krishnamoorthy,et al.  Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections , 2003, Genes and Immunity.

[42]  S. Frøland,et al.  Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. , 2003, Journal of acquired immune deficiency syndromes.

[43]  E. Schurr,et al.  Absence of association between mannose-binding lectin gene polymorphisms and HIV-1 infection in a Colombian population , 2003, Immunogenetics.

[44]  R. Nagel,et al.  Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. , 2003, The American journal of tropical medicine and hygiene.

[45]  C. Mullighan,et al.  Analysis of the Relationship Between Mannose‐Binding Lectin (MBL) Genotype, MBL Levels and Function in an Australian Blood Donor Population , 2002, Scandinavian journal of immunology.

[46]  O. Christiansen,et al.  Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. , 2002, American journal of obstetrics and gynecology.

[47]  L. Chitsulo,et al.  The global epidemiological situation of schistosomiasis and new approaches to control and research. , 2002, Acta tropica.

[48]  J. Jensenius.  Mannose-binding lectin , 2002, The Lancet.

[49]  C. Turner,et al.  The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection. , 2001, Memorias do Instituto Oswaldo Cruz.

[50]  J. Soothill.  Mannose-binding lectin , 2001, The Lancet.

[51]  D. Karanja,et al.  Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. , 2001, The Journal of infectious diseases.

[52]  S. Thiel,et al.  The mannan-binding lectin pathway of complement activation: biology and disease association. , 2001, Molecular immunology.

[53]  M. Feitosa,et al.  Mannan-Binding Lectin Enhances Susceptibility to Visceral Leishmaniasis , 2001, Infection and Immunity.

[54]  D. Jack,et al.  Mannose‐binding lectin: targeting the microbial world for complement attack and opsonophagocytosis , 2001, Immunological reviews.

[55]  M. Melbye,et al.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. , 2001, JAMA.

[56]  L. Chitsulo,et al.  The global status of schistosomiasis and its control. , 2000, Acta tropica.

[57]  Z. Bentwich,et al.  Concurrent infections and HIV pathogenesis , 2000, AIDS.

[58]  J. Jensenius,et al.  Schistosoma mansoni: adhesion of mannan-binding lectin to surface glycoproteins of cercariae and adult worms. , 2000, Experimental parasitology.

[59]  S. Thiel,et al.  Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. , 2000, Journal of immunological methods.

[60]  A. Amoroso,et al.  Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression , 2000, Genes and Immunity.

[61]  M. Kojima,et al.  Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors. , 1999, Molecular immunology.

[62]  D. Zurakowski,et al.  Mannose-Binding Protein B Allele Confers Protection against Tuberculous Meningitis , 1999, Pediatric Research.

[63]  H. Schuitemaker,et al.  Presence of the variant mannose‐binding lectin alleles associated with slower progression to AIDS , 1998, AIDS.

[64]  B. Høgh,et al.  Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. , 1998, Journal of immunology.

[65]  A. Syvänen,et al.  Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. , 1998, AIDS research and human retroviruses.

[66]  S. Thiel,et al.  Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. , 1997, Immunology letters.

[67]  A. Svejgaard,et al.  Mannan‐Binding Lectin in the Sub‐Saharan HIV and Tuberculosis Epidemics , 1997, Scandinavian journal of immunology.

[68]  B. Nahlen,et al.  Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. , 1997, The American journal of tropical medicine and hygiene.

[69]  A. Svejgaard,et al.  Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin , 1997, The Lancet.

[70]  M. Turner,et al.  Mannose-binding lectin: the pluripotent molecule of the innate immune system. , 1996, Immunology today.

[71]  S. Thiel,et al.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. , 1995, Journal of immunology.

[72]  D. Vergani,et al.  Circulating levels of mannose binding protein in human immunodeficiency virus infection. , 1995, The Journal of infection.

[73]  J. Schmidt.  Glycans with N-acetyllactosamine type 2-like residues covering adult Schistosoma mansoni, and glycomimesis as a putative mechanism of immune evasion , 1995, Parasitology.

[74]  M. Turner,et al.  Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. , 1995, Immunology.

[75]  S. Thiel,et al.  The level of the serum opsonin, mannan‐binding protein in HIV‐1 antibody‐positive patients , 1995, Clinical and experimental immunology.

[76]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[77]  J. Caulfield,et al.  Schistosoma mansoni: fractionation and characterization of the glycocalyx and glycogen-like material from cercariae. , 1994, Experimental parasitology.

[78]  S. Thiel,et al.  Complement activation upon binding of mannan‐binding protein to HIV envelope glycoproteins , 1993, AIDS.

[79]  T. Fujita,et al.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease , 1992, The Journal of experimental medicine.

[80]  S. Thiel,et al.  DIALLELIC POLYMORPHISM MAY EXPLAIN VARIATIONS OF THE BLOOD CONCENTRATION OF MANNAN‐BINDING PROTEIN IN ESKIMOS, BUT NOT IN BLACK AFRICANS , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[81]  M. Turner.  DEFICIENCY OF MANNAN BINDING PROTEIN‐A NEW COMPLEMENT DEFICIENCY SYNDROME , 1991, Clinical and experimental immunology.

[82]  Robert B Sim,et al.  Interaction of C1q, and other proteins containing collagen-like domains, with the C1q receptor. , 1990, Biochemical Society transactions.

[83]  D. Vergani,et al.  Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. , 1990, The Journal of infectious diseases.

[84]  J. Groopman,et al.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus , 1989, The Journal of experimental medicine.

[85]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[86]  J. Ehrich,et al.  Circadian variation of ova excretion, proteinuria, hematuria, and leukocyturia in urinary schistosomiasis. , 1985, Kidney international.

[87]  J Leibowitch,et al.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). , 1983, Science.

[88]  K. Mott,et al.  Field studies of a reusable polyamide filter for detection of Schistosoma haematobium eggs by urine filtration. , 1982, Tropenmedizin und Parasitologie.

[89]  R. Hiatt,et al.  A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni eggs. , 1976, The American journal of tropical medicine and hygiene.

[90]  M. C. Weber,et al.  The distribution of viable and non-viable eggs of schistosoma haematobium in the urine. , 1969, The Central African journal of medicine.

[91]  T. Fujita,et al.  The role of MASP-1/3 in complement activation. , 2013, Advances in experimental medicine and biology.

[92]  A. Vallinoto,et al.  Characterization of mannose-binding lectin plasma levels and genetic polymorphisms in HIV-1-infected individuals. , 2011, Revista da Sociedade Brasileira de Medicina Tropical.

[93]  A. Rathore,et al.  Mannose-binding lectin (+54) exon-1 gene polymorphism influence human immunodeficiency virus-1 susceptibility in North Indians. , 2011, Tissue antigens.

[94]  Tao Li,et al.  A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn) , 2009, Cell Research.

[95]  S. Thiel,et al.  A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein , 2004, Immunogenetics.

[96]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[97]  R. Kaslow,et al.  The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy. , 2003, AIDS.

[98]  A. Spurdle,et al.  Mutations in the Human Mannose-Binding Protein Gene: Frequencies in Several Population Groups , 1996, European journal of human genetics : EJHG.

[99]  A. Deelder,et al.  Quantitative diagnosis of Schistosoma infections by measurement of circulating antigens in serum and urine. , 1994, Tropical and geographical medicine.

[100]  Y. Lau,et al.  High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. , 1992, Human molecular genetics.